Search company, investor...

Tissue Therapies


Other Investors | Alive

About Tissue Therapies

Tissue Therapies offers technologies in growth factors and autologous cell therapies.

Headquarters Location

Kelvin Grove



Missing: Tissue Therapies's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Tissue Therapies's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Tissue Therapies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tissue Therapies is included in 1 Expert Collection, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Latest Tissue Therapies News

Novadip's $22 Million B Round for Skeletal Tissue Therapies Includes HK Investor

Oct 28, 2021

publication date: Oct 28, 2021 Novadip Biosciences of Belgium raised $22 million in a Series B round from global investors including CR-CP Life Science Fund of Hong Kong. Novadip is a clinical stage company developing products to regenerate impaired skeletal tissue. Its proprietary 3M3 platform is a 3-dimensional, extracellular matrix that uses adipose-derived stem cells to deliver growth factors and miRNAs that mimic natural healing. The company's lead candidate is an autologous bone product aimed at diseases that include congenital pseudarthrosis of the tibia (CPT), a rare pediatric disease. More details.... Share this with colleagues: Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today? If you are already a subscriber, please login. If you believe you should have received this message in error, please contact us .

Tissue Therapies Frequently Asked Questions (FAQ)

  • What is Tissue Therapies's latest funding round?

    Tissue Therapies's latest funding round is Other Investors.

  • Who are the investors of Tissue Therapies?

    Investors of Tissue Therapies include Bluebox Security.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.